Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,476 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $433.99 | 4 | $0 (2023) |
| Lilly USA, LLC | $346.88 | 7 | $0 (2024) |
| Novo Nordisk Inc | $295.75 | 7 | $0 (2023) |
| Amgen Inc. | $244.50 | 2 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $238.63 | 2 | $0 (2024) |
| AbbVie Inc. | $223.02 | 4 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $108.30 | 1 | $0 (2018) |
| Axsome Therapeutics, Inc. | $107.52 | 1 | $0 (2024) |
| MDD US Operations, LLC | $100.00 | 1 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $89.15 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $294.94 | 5 | Neurocrine Biosciences, Inc. ($135.55) |
| 2023 | $397.08 | 12 | MDD US Operations, LLC ($100.00) |
| 2022 | $162.49 | 6 | IDORSIA PHARMACEUTICALS US INC ($89.15) |
| 2021 | $88.88 | 1 | AbbVie Inc. ($88.88) |
| 2020 | $125.12 | 1 | AstraZeneca Pharmaceuticals LP ($125.12) |
| 2019 | $314.24 | 5 | Neurocrine Biosciences, Inc. ($103.08) |
| 2018 | $482.70 | 8 | Lilly USA, LLC ($198.89) |
| 2017 | $610.09 | 8 | Amgen Inc. ($244.50) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $135.55 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $107.52 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/09/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: NEUROLOGY | ||||||
| 07/13/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes Care | ||||||
| 06/07/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Neurology | ||||||
| 05/11/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Immunology | ||||||
| 03/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $87.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Diabetes Care | ||||||
| 02/09/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Diabetes | ||||||
| 01/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
| 12/16/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $61.20 | General |
| Category: INSOMNIA | ||||||
| 12/07/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Endocrinology | ||||||
| 11/11/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: INSOMNIA | ||||||
| 11/09/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
| 07/25/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes Care | ||||||
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $88.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $125.12 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 756 | 1,521 | $140,126 | $95,695 |
| 2022 | 18 | 1,362 | 2,430 | $235,554 | $134,716 |
| 2021 | 23 | 1,225 | 2,538 | $265,149 | $163,984 |
| 2020 | 37 | 2,380 | 5,261 | $504,960 | $273,106 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 979 | $110,203 | $73,206 | 66.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $10,588 | $10,161 | 96.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 73 | $5,553 | $4,015 | 72.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 16 | 16 | $1,815 | $1,154 | 63.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $1,947 | $1,124 | 57.8% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 11 | 11 | $1,374 | $985.93 | 71.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 89 | $1,368 | $937.40 | 68.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $860.75 | $843.55 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 48 | 48 | $948.10 | $776.80 | 81.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 89 | 90 | $2,815 | $756.00 | 26.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 13 | 13 | $714.74 | $556.27 | 77.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 13 | 13 | $556.66 | $430.95 | 77.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 13 | 13 | $754.39 | $381.42 | 50.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $354.80 | $299.64 | 84.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 12 | $275.01 | $66.15 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 326 | 1,095 | $161,392 | $93,985 | 58.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 103 | 103 | $16,038 | $13,211 | 82.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 21 | 21 | $6,212 | $4,043 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 60 | $6,094 | $3,694 | 60.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 195 | 195 | $4,644 | $3,470 | 74.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 189 | 189 | $4,543 | $3,348 | 73.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 17 | 17 | $4,685 | $2,526 | 53.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,145 | $1,694 | 53.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 69 | 70 | $1,400 | $1,374 | 98.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 67 | 68 | $1,700 | $1,364 | 80.2% |
About Dr. Jaime Gonzalez, MD
Dr. Jaime Gonzalez, MD is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316936461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaime Gonzalez, MD has received a total of $2,476 in payments from pharmaceutical and medical device companies, with $294.94 received in 2024. These payments were reported across 46 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,476).
As a Medicare-enrolled provider, Gonzalez has provided services to 5,723 Medicare beneficiaries, totaling 11,750 services with total Medicare billing of $667,500. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Clermont, FL
- Active Since 10/20/2005
- Last Updated 02/04/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316936461
Products in Payments
- TRULICITY (Drug) $307.07
- INGREZZA (Drug) $238.63
- BREZTRI AEROSPHERE (Drug) $125.12
- SYMBICORT (Drug) $125.00
- Prolia (Biological) $122.95
- Repatha (Biological) $121.55
- INVOKANA (Drug) $108.30
- Auvelity (Drug) $107.52
- GOCOVRI (Drug) $100.00
- Xultophy 100/3.6 (Drug) $99.62
- Tresiba (Drug) $93.77
- QUVIVIQ (Drug) $89.15
- UBRELVY (Drug) $88.88
- FARXIGA (Drug) $87.52
- Rybelsus (Drug) $79.03
- APTIOM (Drug) $74.86
- FREESTYLE LIBRE 2 (Device) $58.46
- ELIQUIS (Drug) $45.65
- MOUNJARO (Drug) $39.81
- TREMFYA (Drug) $27.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clermont
Sumith Aleti, Md, MD
Internal Medicine — Payments: $29,143
Alexander Bolanos, M.d, M.D
Internal Medicine — Payments: $15,769
Nathan Bibliowicz, Do, DO
Internal Medicine — Payments: $14,320
Dr. Shazia Nasir, Md, MD
Internal Medicine — Payments: $11,207
Carolina Mejia Otero, M.d, M.D
Internal Medicine — Payments: $7,926
Dr. Kiran Mogali, M.d, M.D
Internal Medicine — Payments: $7,620